{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:59:55Z","timestamp":1792511995131,"version":"4.5.0"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>Inborn errors of immunity (IEIs) caused by mutations in <jats:italic>STAT1<\/jats:italic> are associated with a broad range of clinical manifestations, ranging from relatively mild to life-threatening. Our aim was to give a clinical and molecular description of a Norwegian cohort with STAT1-related disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This is a descriptive epidemiological study.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We present 23 patients with heterozygous <jats:italic>STAT1<\/jats:italic> mutations, from 12 unrelated Norwegian families. Eighteen individuals had <jats:italic>STAT1 gain-of-function<\/jats:italic> (GOF) variants. Chronic mucocutaneous candidiasis (CMC) was the most common manifestation, observed in 94% of patients. Herpesviruses caused morbidity in one-third of patients, with severe complications such as varicella meningitis, varicella retinitis and ulcerative CMV esophagitis seen in 17%. Autoimmune hypertriglyceridemia with GPIHBP1 autoantibodies was diagnosed in one patient, adding a new entity to STAT1 GOF. Fifty percent of patients suffered chronic ophthalmologic manifestations. Severe gastrointestinal manifestations were observed in 22% of patients. Five of the 23 patients had <jats:italic>STAT1 loss-of-function<\/jats:italic> (LOF) variants. Mendelian susceptibility to mycobacterial disease (MSMD) was detected in three patients. Malignancy and autoimmunity were observed in two patients, both were heterozygous for the p.Ala246Thr variant, which is likely associated with a more complex phenotype. Significant viral infections were also observed. Presently, our cohort represents the largest nationwide study on STAT1-related disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>We report novel clinical manifestations in STAT1 GOF, and suggest that heterozygous STAT1 LOF might be a more complex condition than originally presumed.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1620291","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T09:30:51Z","timestamp":1755077451000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["A Norwegian cohort with STAT1-related disease \u2013 further expanding the clinical phenotype"],"prefix":"10.3389","volume":"16","author":[{"given":"Karen Helene Bronken","family":"Martinsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torstein","family":"\u00d8verland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asbj\u00f8rg","family":"Stray-Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tore G.","family":"Abrahamsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00f8rre","family":"Fevang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Christian Erichsen","family":"Landsverk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.coi.2021.02.009","article-title":"Inborn errors of STAT1 immunity","volume":"72","author":"Mizoguchi","year":"2021","journal-title":"Curr Opin Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s10875-019-00688-3","article-title":"Molecular and phenotypic characterization of nine patients with STAT1 GOF mutations in China","volume":"40","author":"Chen","year":"2020","journal-title":"J Clin Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-020-00847-x","article-title":"Human STAT1 gain-of-function heterozygous mutations: chronic mucocutaneous candidiasis and type I interferonopathy","volume":"40","author":"Okada","year":"2020","journal-title":"J Clin Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2018.1531704","article-title":"STAT1 and STAT3 mutations: important lessons for clinical immunologists","volume":"14","author":"Olbrich","year":"2018","journal-title":"Expert Rev Clin Immunol J Translated Name Expert Rev Clin Immunol Keyword Heading chronic mucocutaneous candidiasis Gain Funct (GOF) STAT1 gain Funct (GOF) STAT3 hyper IgE syndrome Job\u2019s syndrom"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-023-01483-x","article-title":"JAKs and STATs from a clinical perspective: loss-of-function mutations, gain-of-function mutations, and their multidimensional consequences","volume":"43","author":"Ott","year":"2023","journal-title":"J Clin Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1929.01930080104011","article-title":"CHRONIC TETANY AND CHRONIC MYCELIAL STOMATITIS IN A CHILD AGED FOUR AND ONE-HALF YEARS","volume":"38","author":"Thorpe JR","year":"1929","journal-title":"Am J Dis Children"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-11-679902","article-title":"Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype","volume":"127","author":"Toubiana","year":"2016","journal-title":"Blood"},{"key":"B8","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1056\/NEJMoa1100102","article-title":"STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis","volume":"365","author":"van de Veerdonk","year":"2011","journal-title":"N Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.654406","article-title":"Clinical relevance of gain- and loss-of-function germline mutations in STAT1: A systematic review","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.jaci.2023.10.018","article-title":"JAK inhibitor treatment for inborn errors of JAK\/STAT signaling: An ESID\/EBMT-IEWP retrospective study","volume":"153","author":"Fischer","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.1002140","article-title":"A novel STAT1 loss-of-function mutation associated with Mendelian susceptibility to mycobacterial disease","volume":"12","author":"Ye","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2001451","article-title":"Genetic, immunological, and clinical features of 32 patients with autosomal recessive STAT1 deficiency","volume":"207","author":"Le Voyer","year":"2021","journal-title":"J Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s00439-020-02120-y","article-title":"Mendelian susceptibility to mycobacterial disease: recent discoveries","volume":"139","author":"Bustamante","year":"2020","journal-title":"Hum Genet"},{"key":"B14","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.iac.2020.03.002","article-title":"The importance of primary immune deficiency registries: the United States immunodeficiency network registry","volume":"40","author":"Lopes","year":"2020","journal-title":"Immunol Allergy Clin North Am"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2023.11.002","article-title":"Molecular genetic testing and measurement of levels of GPIHBP1 autoantibodies in patients with severe hypertriglyceridemia: The importance of identifying the underlying cause of hypertriglyceridemia","volume":"18","author":"Strom","year":"2023","journal-title":"J Clin Lipidol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.R120001116","article-title":"Chylomicronemia from GPIHBP1 autoantibodies","volume":"61","author":"Miyashita","year":"2020","journal-title":"J Lipid Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1097\/ACI.0000000000001039","article-title":"STAT1 and STAT3 gain of function: clinically heterogenous immune regulatory disorders","volume":"24","author":"Olbrich","year":"2024","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/imr.v322.1","article-title":"Human STAT1 gain of function with chronic mucocutaneous candidiasis: A comprehensive review for strengthening the connection between bedside observations and laboratory research","volume":"322","author":"Asano","year":"2024","journal-title":"Immunol Rev"},{"key":"B19","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1007\/s10875-020-00942-z","article-title":"Pediatric demodicosis associated with gain-of-function variant in STAT1 presenting as rosacea-type rash","volume":"41","author":"Baghad","year":"2021","journal-title":"J Clin Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.760019","article-title":"Case report: A new gain-of-function mutation of STAT1 identified in a patient with chronic mucocutaneous candidiasis and rosacea-like demodicosis: an emerging association","volume":"12","author":"Martinot","year":"2021","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/pde.14011","article-title":"STAT1 gain-of-function and chronic demodicosis","volume":"37","author":"Molho-Pessach","year":"2020","journal-title":"Pediatr Dermatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13103","article-title":"Treatment of Demodex-associated inflammatory skin conditions: A systematic review","volume":"32","author":"Jacob","year":"2019","journal-title":"Dermatol Ther"},{"key":"B23","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1001\/archdermatol.2010.196","article-title":"Retrospective analysis of the association between Demodex infestation and rosacea","volume":"146","author":"Zhao","year":"2010","journal-title":"Arch Dermatol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000003785","article-title":"Ocular rosacea: an updated review","volume":"44","author":"Mohamed-Noriega","year":"2025","journal-title":"Cornea"},{"key":"B25","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1093\/cei\/uxac106","article-title":"Inborn errors of immunity with loss- and gain-of-function germline mutations in STAT1","volume":"212","author":"Asano","year":"2023","journal-title":"Clin Exp Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-022-01339-w","article-title":"Genetic and functional identifying of novel STAT1 loss-of-function mutations in patients with diverse clinical phenotypes","volume":"42","author":"Chen","year":"2022","journal-title":"J Clin Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2023.04.015","article-title":"The th17\/IL-17 axis and host defense against fungal infections","volume":"11","author":"Tangye","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.ade7028","article-title":"Dysregulated IFN-gamma signals promote autoimmunity in STAT1 gain-of-function syndrome","volume":"15","author":"Largent","year":"2023","journal-title":"Sci Transl Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.11.054","article-title":"Dominant gain-of-function STAT1 mutations in FOXP3 wild-type immune dysregulation-polyendocrinopathy-enteropathy-X-linked-like syndrome","volume":"131","author":"Uzel","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10875-015-0214-9","article-title":"The extended clinical phenotype of 26 patients with chronic mucocutaneous candidiasis due to gain-of-function mutations in STAT1","volume":"36","author":"Depner","year":"2016","journal-title":"J Clin Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.01.004","article-title":"Gain-of-function STAT1 mutations are associated with PD-L1 overexpression and a defect in B-cell survival","volume":"131","author":"Romberg","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.jaci.2016.10.051","article-title":"Impaired natural killer cell functions in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations","volume":"140","author":"Tabellini","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-019-00687-4","article-title":"Novel gain-of-function mutation in stat1 sumoylation site leads to CMC\/CID phenotype responsive to ruxolitinib","volume":"39","author":"Al Shehri","year":"2019","journal-title":"J Clin Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M116.753848","article-title":"Molecular mechanism and structural basis of gain-of-function of STAT1 caused by pathogenic R274Q mutation","volume":"292","author":"Fujiki","year":"2017","journal-title":"J Biol Chem"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.05.042","article-title":"Primary immunodeficiency diseases: Genomic approaches delineate heterogeneous Mendelian disorders","volume":"139","author":"Stray-Pedersen","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.09.035","article-title":"Alanine-scanning mutagenesis of human signal transducer and activator of transcription 1 to estimate loss- or gain-of-function variants","volume":"140","author":"Kagawa","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0513250","article-title":"Simple diagnosis of STAT1 gain-of-function alleles in patients with chronic mucocutaneous candidiasis","volume":"95","author":"Mizoguchi","year":"2014","journal-title":"J Leukoc Biol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00274","article-title":"A novel heterozygous mutation in the STAT1 SH2 domain causes chronic mucocutaneous candidiasis, atypically diverse infections, autoimmunity, and impaired cytokine regulation","volume":"8","author":"Meesilpavikkai","year":"2017","journal-title":"Front Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1002\/humu.22113","article-title":"Dominant-negative STAT1 SH2 domain mutations in unrelated patients with Mendelian susceptibility to mycobacterial disease","volume":"33","author":"Tsumura","year":"2012","journal-title":"Hum Mutat"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1620291\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T09:30:51Z","timestamp":1755077451000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1620291\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,13]]},"references-count":39,"alternative-id":["10.3389\/fimmu.2025.1620291"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1620291","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,13]]},"article-number":"1620291"}}